The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

In the United States, the overall probability of dying from a chronic disease fell markedly from 2001 to 2010 but remained nearly flat over...

Russia's cancer vaccine, comprising EnteroMix and personalized mRNA vaccines, has completed preclinical trials, showcasing safety and high ...

Russia's Enteromix vaccine has demonstrated 100% efficacy in preclinical trials, showing promise in fighting tumors. The vaccine, initially...

Russia's Federal Medical Biological Agency (FMBA) has announced the successful completion of preclinical trials for its cancer vaccine, dem...

Russia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innov...

India's Thiruvananthapuram has become a vaccine superpower, producing 60 per cent of the world's vaccines, with significant contributions f...

Russia has developed an mRNA cancer vaccine and plans to release it publicly in early 2025, free of charge. Pre-clinical trials show it inh...

A study published in The Lancet's eClinicalMedicine journal reveals that over 1.3 million lives are lost annually due to tobacco-related ca...

President Vladimir Putin has boasted that Russia is the global leader in hypersonic missiles, capable of travelling at speeds of up to Mach...

The Lancet revealed that Africa followed Asia (20%), Europe (10%) and Latin America (10%) and more than half of deaths were estimated in As...

Some researchers believe the strong immune response that caused problems with gene therapy makes these vectors well suited to vaccines, whe...

"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trial...

At present, there are nine nuclear power reactors at various stages of construction" that are targeted for completion by 2024-25.

Moscow, Dec 9 (IANS) In collaboration with researchers from Assam's Tezpur University, Russian scientists have developed a substance-based ...

SC's decision to deny patent to Novartis will negatively impact the investment in medical, tech advancements, the US Chamber of Commerce sa...

Hyderabad based Dr Reddy’s Laboratories (DRL) has received the final approval from the US Food and Drug Administration (USFDA) for another ...